Merck, 08062522-1VL, B82 (Hamprecht)

Application
Used in the generation of cell hybrids.
Biochem/physiol Actions
An 8-bromodeoxyuridine resistant mutant of mouse L cell fibroblasts (Mouse strain C3H/An). B82 lacks thymidine kinase and was isolated by virtue of resistance to 8-bromodeoxyuridine (30 μg/ml). ECACC has two catalogue entries for the B82 cell line which differ in that they were deposited by different groups: B82 (Sigma Catalogue number 85011408) and B82(Hamprecht) (Sigma Catalogue number 08062522). Several other cell lines in the ECACC catalogue have been derived from B82(Hamprecht).
Mouse Fibroblast (L cells)
Preparation Note
DMEM + 2 mM glutamine + 10% Foetal Bovine Serum (FBS) + 1 mM 8-bromodeoxyuridine
Split sub-confluent cultures (70-80%) 1:3 to 1:6 i.e. seeding at 2-4x10,000 cells/cm² using 0.05% trypsin/EDTA; 5% CO₂; 37°C.
Other Notes
Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.
This cell line is part of the European Collection of Authenticated Cell Cultures (ECACC), an international repository managed by the United Kingdom Health Security Agency (UKHSA). No licensing agreement is required when either this cell line or the DNA extracted from it are used for internal research purposes only. Any other use of these products is prohibited without the express written permission of UKHSA. Inquiries regarding authorized use of this cell line or its genomic DNA may be directed to [email protected].